Trial Details

COMPLETED
Basic Information
Clinical ID c2148
Identifier NCT03915769
Trial Title To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Colitis, Ulcerative
Interventions DRUG: Ozanimod|OTHER: Placebo
Participant Information
Sponsor Celgene
City Hokkaido
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2019-06-03
Primary Completion Date 2025-09-30
Completion Date 2025-09-30